Results 161 to 170 of about 2,805,472 (344)

What do I do to avoid sexually transmitted diseases? A scale development study: behavioral scale for protection from sexually transmitted diseases. [PDF]

BMC Womens Health, 2023
Kılavuz M, Yigit F.
europepmc   +1 more source

Potential Risks of Virtual Influencer Diversity in Charitable Endorsements: A Cognitive Dissonance Perspective

Journal of Consumer Behaviour, EarlyView.
ABSTRACT Highlighting diversity‐related attributes has become an increasingly prominent marketing communication strategy in virtual influencer endorsement practices. Prior research has largely focused on commercial endorsement contexts, conceptualized diversity as a homogeneous and single‐dimensional construct, and emphasized its predominantly positive
Chi‐Cheng Luan, Su Zhang, I‐Lien Li
wiley   +1 more source

Sexually Transmitted Diseases-An Update and Overview of Current Research. [PDF]

Diagnostics (Basel), 2023
Wihlfahrt K, Günther V, Mendling W, Westermann A, Willer D, Gitas G, Ruchay Z, Maass N, Allahqoli L, Alkatout I.   +9 more
europepmc   +1 more source

The Effect of Abortion Liberalization on Sexual Behavior: International Evidence [PDF]

Most industrialized countries have increased access to abortion over the past 30 years. Economic theory predicts that abortion laws affect sexual behavior since they change the marginal cost of having risky sex.
Sven Neelsen, Jonathan Klick, Thomas Stratmann   +2 more
core  

Prediction of Prevalent Cardiovascular Disease Using Social, Environmental, and Behavioral Factors: A Vital Conditions Framework Approach

Chronic Diseases and Translational Medicine, EarlyView.
The Vital Conditions Framework. Graphical representation of the Vital Conditions for Health Framework with seven domains. Images used with permission from The Rippel Foundation: An Introduction to the Vital Conditions for Health and Well‐Being. https://rippel.org/events/webinar-an-introduction-to-the-vital-conditions-for-health-and-well-being/. Federal
Stephanie Kjelstrom, Richard Hass, Robert Vollbrecht, Brandon George, Sharon Larson   +4 more
wiley   +1 more source

Sexually transmitted disease (STD) preventive services : 2016 gap assessment toolkit

Persons in need of sexually transmitted disease(STD) prevention services frequently also need other health and social services. STD prevention programs and certain other health care facilities offer an arrayof preventive services and often link persons ...

core  

Transcriptomic Profiling of SLC and ABC Transporters in the Human Term Placenta

Clinical Pharmacology &Therapeutics, EarlyView.
Solute carriers (SLC) and ATP‐binding cassette (ABC) transporters are essential for placental solute exchange and fetal protection, yet their transcriptomic profiles in the human placenta remain poorly characterized. Although fetal sex influences placental development and function, its impact on transporter expression is unclear.
Elijah Marsh Jung, Nicholas Ieronimakis, Bothaina Mousa, Emily D. Sheikh, Sarah E. Ligon, Joshua W. Monson, Jennifer R. Damicis, Hillary J. Kinsman, Lydia E. Bettridge, Samuel L.M. Arnold, Edward J. Kelly, Jashvant D. Unadkat, Joanne Wang   +12 more
wiley   +1 more source

Comparison of first void urine and urogenital swab specimens for detection of Mycoplasma genitalium and Chlamydia trachomatis by polymerase chain reaction in patients attending a sexually transmitted disease clinic

, 2004
OBJECTIVE: The objective of this study was to compare urogenital swab specimens and first void urine (FVU) specimens from male and female patients at a sexually transmitted disease clinic for the detection of Mycoplasma genitalium and Chlamydia ...
Dohn, B, Jensen, JS, Lidbrink, P, Björnelius, E   +3 more
core   +1 more source

Phase I Evaluation of Siltartoxatug, a First‐in‐Class Anti‐Tetanus Monoclonal Antibody: Safety, Pharmacokinetics and Pharmacodynamics in Healthy Australian and Chinese Populations

Clinical Pharmacology &Therapeutics, EarlyView.
Siltartoxatug, a first‐in‐class monoclonal antibody targeting tetanus toxin for post‐exposure prophylaxis, was evaluated in two phase I trials in Australian and Chinese healthy adults. In these randomized, double‐blind, placebo‐controlled, dose‐escalation studies, participants received a single intramuscular injection of siltartoxatug (10–250 μg/kg) or
Xinyu Liu, Zhigang Liu, Xiaohu Kuang, Yueming Wang, Xiaoyi Liu, Jiyuan Ding, Xia Zhou, Xin Zhou, Qianyu Liang, Meizhuo Zhang, Hao Zhao, Qingqing Tan, Weihong Zheng, Huaxin Liao, Charlotte Lemech, Wanmei Wang   +15 more
wiley   +1 more source

Evaluation of dual path platform optical density in relation to RPR titers and serological response in syphilis: a cross-sectional and longitudinal study

International Journal of Infectious Diseases
Objectives: The Dual Path Platform (DPP) detects treponemal and lipoidal antibodies at the point of care, with an automated reader generating quantitative optical density (OD) values.
Sara Buezo, Roser Escrig-Sarreta, Dan Ouchi, Maria Ubals, Gema Fernández Rivas, Mariona Cortacans Castellà, Mariona Bonastre Marqués, Patricia Nadal, Eva Dopico, Clara Pérez-Mañá, Susana Muñoz, Xinying Leng, Clara Suñer, Maider Arando, Adrià Mendoza, Ángel Rivero, Martí Vall-Mayans, Camila G. Beiras, Oriol Mitjà   +18 more
doaj   +1 more source